TUBIZE FIN (Belgium) Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for TUBIZE FIN are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 19, 2019 and ending today October 17, 2019. Click here to learn more.
TUBIZE FIN cannot be verified against its exchange. Apparently, TUBIZE FIN is not available for investing at the moment. Please verify the symbol is currently traded on Brussels Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

TUBIZE FIN Profile

Financire de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. The companys products in pipeline include UCB0942 for drug resistant epilepsy UCB3491 for infantile epilepsy UCB0599 for Parkinsons disease UCB7858UCB0159 for auto-inflammatory diseases UCB6673 to treat immunological diseases UCB4144VR942 to treat asthma seletalisib for treating Sjrgens syndrome dapirolizumab pegol for systemic lupus erythematosus bimekizumab to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis rozanolixizumab to treat immune thrombocytopenia and myasthenia gravis and romosozumab for post-menopausal osteoporosis and osteoporosis in men. TUBIZE FIN operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange.. The public information regarding TUBIZE FIN's current market price is not available at this time.
NameTUBIZE FIN
ChairmanFrancois TeschView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentBelgium Stock View All
Business AddressAllée de la Recherche 60
ExchangeBrussels Stock Exchange
ISINBE0003823409
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.financiere-tubize.be
Phone32 4 764 90 844
CurrencyEUR - Euro
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
TUBIZE FIN (TUB) is traded on Brussels Stock Exchange in Belgium and employs 6 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.76 B. TUBIZE FIN operates under Healthcare sector and is part of Biotechnology industry. The entity has 38.95 M outstanding shares. FINANCIERE TUBIZE has accumulated about 1.02 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check TUBIZE FIN Probability Of Bankruptcy

TUBIZE FIN Top Holders

TUBIZE FIN Key Fundamentals

TUBIZE FIN Against Markets

TUBIZE FIN cannot be verified against its exchange. Apparently, TUBIZE FIN is not available for investing at the moment. Please verify the symbol is currently traded on Brussels Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Financire de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. The companys products in pipeline include UCB0942 for drug resistant epilepsy UCB3491 for infantile epilepsy UCB0599 for Parkinsons disease UCB7858UCB0159 for auto-inflammatory diseases UCB6673 to treat immunological diseases UCB4144VR942 to treat asthma seletalisib for treating Sjrgens syndrome dapirolizumab pegol for systemic lupus erythematosus bimekizumab to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis rozanolixizumab to treat immune thrombocytopenia and myasthenia gravis and romosozumab for post-menopausal osteoporosis and osteoporosis in men. TUBIZE FIN operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange.. The public information regarding TUBIZE FIN's current market price is not available at this time.
NameTUBIZE FIN
ChairmanFrancois TeschView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentBelgium Stock View All
Business AddressAllée de la Recherche 60
ExchangeBrussels Stock Exchange
ISINBE0003823409
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.financiere-tubize.be
Phone32 4 764 90 844
CurrencyEUR - Euro
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018

TUBIZE FIN Corporate Directors

See also World Market Map. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com